Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Glycoprotein I of varicella-zoster virus is required for viral replication in skin and T cells.

Literature DB >> 12134050

Glycoprotein I of varicella-zoster virus is required for viral replication in skin and T cells.

Jennifer Moffat¹, Hideki Ito, Marvin Sommer, Shannon Taylor, Ann M Arvin.

Abstract

Varicella-zoster virus (VZV) glycoprotein I (gI) is dispensable in cell culture; the SCIDhu model of VZV pathogenesis was used to determine whether gI is necessary in vivo. The parental and repaired viruses grew in human skin and thymus/liver implants, but the gI deletion mutant was not infectious. Thus, gI is essential for VZV infectivity in skin and T cells.

Entities: Species

Mesh：

Substances：

Year: 2002 PMID： 12134050 PMCID： PMC155157 DOI： 10.1128/jvi.76.16.8468-8471.2002

Source DB: PubMed Journal: J Virol ISSN： 0022-538X Impact factor: 5.103

16 in total

1. Trafficking of varicella-zoster virus glycoprotein gI: T(338)-dependent retention in the trans-Golgi network, secretion, and mannose 6-phosphate-inhibitable uptake of the ectodomain.

Authors: Z H Wang; M D Gershon; O Lungu; Z Zhu; A A Gershon
Journal: J Virol Date: 2000-07 Impact factor: 5.103

Review 2. Glycoproteins encoded by varicella-zoster virus: biosynthesis, phosphorylation, and intracellular trafficking.

Authors: C Grose
Journal: Annu Rev Microbiol Date: 1990 Impact factor: 15.500

3. Essential role played by the C-terminal domain of glycoprotein I in envelopment of varicella-zoster virus in the trans-Golgi network: interactions of glycoproteins with tegument.

Authors: Z H Wang; M D Gershon; O Lungu; Z Zhu; S Mallory; A M Arvin; A A Gershon
Journal: J Virol Date: 2001-01 Impact factor: 5.103

4. The complete DNA sequence of varicella-zoster virus.

Authors: A J Davison; J E Scott
Journal: J Gen Virol Date: 1986-09 Impact factor: 3.891

5. Investigation of varicella-zoster virus infection of lymphocytes by in situ hybridization.

Authors: C M Koropchak; S M Solem; P S Diaz; A M Arvin
Journal: J Virol Date: 1989-05 Impact factor: 5.103

6. Varicella-zoster virus glycoprotein gpI/gpIV receptor: expression, complex formation, and antigenicity within the vaccinia virus-T7 RNA polymerase transfection system.

Authors: Z Yao; W Jackson; B Forghani; C Grose
Journal: J Virol Date: 1993-01 Impact factor: 5.103

7. Endocytosis and recycling of varicella-zoster virus Fc receptor glycoprotein gE: internalization mediated by a YXXL motif in the cytoplasmic tail.

Authors: J K Olson; C Grose
Journal: J Virol Date: 1997-05 Impact factor: 5.103

8. The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse.

Authors: J F Moffat; L Zerboni; M H Sommer; T C Heineman; J I Cohen; H Kaneshima; A M Arvin
Journal: Proc Natl Acad Sci U S A Date: 1998-09-29 Impact factor: 11.205

9. Tropism of varicella-zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice.

Authors: J F Moffat; M D Stein; H Kaneshima; A M Arvin
Journal: J Virol Date: 1995-09 Impact factor: 5.103

10. The requirement of varicella zoster virus glycoprotein E (gE) for viral replication and effects of glycoprotein I on gE in melanoma cells.

Authors: Chengjun Mo; Jay Lee; Marvin Sommer; Charles Grose; Ann M Arvin
Journal: Virology Date: 2002-12-20 Impact factor: 3.616

38 in total

1. Essential functions of the unique N-terminal region of the varicella-zoster virus glycoprotein E ectodomain in viral replication and in the pathogenesis of skin infection.

Authors: Barbara Berarducci; Minako Ikoma; Shaye Stamatis; Marvin Sommer; Charles Grose; Ann M Arvin
Journal: J Virol Date: 2006-10 Impact factor: 5.103

Review 2. Varicella-Zoster virus pathogenesis and immunobiology: new concepts emerging from investigations with the SCIDhu mouse model.

Authors: Chia-Chi Ku; Jaya Besser; Allison Abendroth; Charles Grose; Ann M Arvin
Journal: J Virol Date: 2005-03 Impact factor: 5.103

3. The ubiquitous cellular transcriptional factor USF targets the varicella-zoster virus open reading frame 10 promoter and determines virulence in human skin xenografts in SCIDhu mice in vivo.

Authors: Xibing Che; Barbara Berarducci; Marvin Sommer; William T Ruyechan; Ann M Arvin
Journal: J Virol Date: 2007-01-24 Impact factor: 5.103

4. The C-terminus of varicella-zoster virus glycoprotein M contains trafficking motifs that mediate skin virulence in the SCID-human model of VZV pathogenesis.

Authors: Leigh Zerboni; Phillip Sung; Marvin Sommer; Ann Arvin
Journal: Virology Date: 2018-08-14 Impact factor: 3.616

5. The insulin degrading enzyme binding domain of varicella-zoster virus (VZV) glycoprotein E is important for cell-to-cell spread and VZV infectivity, while a glycoprotein I binding domain is essential for infection.

Authors: Mir A Ali; Qingxue Li; Elizabeth R Fischer; Jeffrey I Cohen
Journal: Virology Date: 2009-02-23 Impact factor: 3.616

6. Varicella-zoster virus ORF47 protein kinase, which is required for replication in human T cells, and ORF66 protein kinase, which is expressed during latency, are dispensable for establishment of latency.

Authors: Hitoshi Sato; Lesley Pesnicak; Jeffrey I Cohen
Journal: J Virol Date: 2003-10 Impact factor: 5.103